世界のコンパニオン診断技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Companion Diagnostic Technologies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4045 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、コンパニオン診断技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫組織化学、分子診断）、用途別市場規模（腫瘍学、心臓血管、中枢神経系、自己免疫&炎症、ウイルス学、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・コンパニオン診断技術の市場動向 ・企業の競争状況、市場シェア ・コンパニオン診断技術の種類別市場規模と予測2016-2027（免疫組織化学、分子診断） ・コンパニオン診断技術の用途別市場規模と予測2016-2027（腫瘍学、心臓血管、中枢神経系、自己免疫&炎症、ウイルス学、その他） ・コンパニオン診断技術の北米市場規模2016-2027（アメリカ、カナダ） ・コンパニオン診断技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・コンパニオン診断技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・コンパニオン診断技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・コンパニオン診断技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dako (Agilent Technologies)、Qiagen、Roche、Abbott Laboratories、Thermo Fisher Scientific、bioMerieux、Myriad Genetics、Resonance Health Ltd.、Leica Microsystems、Danaher） ・結論

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.
Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.

Market Analysis and Insights: Global Companion Diagnostic Technologies Market
The global Companion Diagnostic Technologies market size is projected to reach US$ 6057.7 million by 2027, from US$ 2771.3 million in 2020, at a CAGR of 11.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Technologies market.

Global Companion Diagnostic Technologies Scope and Market Size
Companion Diagnostic Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunohistochemistry
Molecular Diagnostics

Segment by Application
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Companion Diagnostic Technologies Market Perspective (2016-2027)
2.2 Companion Diagnostic Technologies Growth Trends by Regions
2.2.1 Companion Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Diagnostic Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Regions (2022-2027)
2.3 Companion Diagnostic Technologies Industry Dynamic
2.3.1 Companion Diagnostic Technologies Market Trends
2.3.2 Companion Diagnostic Technologies Market Drivers
2.3.3 Companion Diagnostic Technologies Market Challenges
2.3.4 Companion Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Technologies Players by Revenue
3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2016-2021)
3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2020
3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Technologies Breakdown Data by Type
4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2016-2021)
4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2022-2027)

5 Companion Diagnostic Technologies Breakdown Data by Application
5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2016-2021)
5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Companion Diagnostic Technologies Market Size (2016-2027)
6.2 North America Companion Diagnostic Technologies Market Size by Type
6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2016-2021)
6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2022-2027)
6.2.3 North America Companion Diagnostic Technologies Market Size by Type (2016-2027)
6.3 North America Companion Diagnostic Technologies Market Size by Application
6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2016-2021)
6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2022-2027)
6.3.3 North America Companion Diagnostic Technologies Market Size by Application (2016-2027)
6.4 North America Companion Diagnostic Technologies Market Size by Country
6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2016-2021)
6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Companion Diagnostic Technologies Market Size (2016-2027)
7.2 Europe Companion Diagnostic Technologies Market Size by Type
7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2016-2021)
7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2022-2027)
7.2.3 Europe Companion Diagnostic Technologies Market Size by Type (2016-2027)
7.3 Europe Companion Diagnostic Technologies Market Size by Application
7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2016-2021)
7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2022-2027)
7.3.3 Europe Companion Diagnostic Technologies Market Size by Application (2016-2027)
7.4 Europe Companion Diagnostic Technologies Market Size by Country
7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2016-2021)
7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2016-2027)
8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2027)
8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2027)
8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Companion Diagnostic Technologies Market Size (2016-2027)
9.2 Latin America Companion Diagnostic Technologies Market Size by Type
9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2022-2027)
9.2.3 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2027)
9.3 Latin America Companion Diagnostic Technologies Market Size by Application
9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2022-2027)
9.3.3 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2027)
9.4 Latin America Companion Diagnostic Technologies Market Size by Country
9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2016-2027)
10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2027)
10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2027)
10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dako (Agilent Technologies)
11.1.1 Dako (Agilent Technologies) Company Details
11.1.2 Dako (Agilent Technologies) Business Overview
11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.1.5 Dako (Agilent Technologies) Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Companion Diagnostic Technologies Introduction
11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.2.5 Qiagen Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Companion Diagnostic Technologies Introduction
11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.6.5 bioMerieux Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Details
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.7.5 Myriad Genetics Recent Development
11.8 Resonance Health Ltd.
11.8.1 Resonance Health Ltd. Company Details
11.8.2 Resonance Health Ltd. Business Overview
11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.8.5 Resonance Health Ltd. Recent Development
11.9 Leica Microsystems
11.9.1 Leica Microsystems Company Details
11.9.2 Leica Microsystems Business Overview
11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.9.5 Leica Microsystems Recent Development
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Technologies Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2016-2021)
11.10.5 Danaher Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Companion Diagnostic Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunohistochemistry
Table 3. Key Players of Molecular Diagnostics
Table 4. Global Companion Diagnostic Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Companion Diagnostic Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Companion Diagnostic Technologies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Companion Diagnostic Technologies Market Share by Regions (2016-2021)
Table 8. Global Companion Diagnostic Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Companion Diagnostic Technologies Market Share by Regions (2022-2027)
Table 10. Companion Diagnostic Technologies Market Trends
Table 11. Companion Diagnostic Technologies Market Drivers
Table 12. Companion Diagnostic Technologies Market Challenges
Table 13. Companion Diagnostic Technologies Market Restraints
Table 14. Global Companion Diagnostic Technologies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Companion Diagnostic Technologies Market Share by Players (2016-2021)
Table 16. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Technologies as of 2020)
Table 17. Ranking of Global Top Companion Diagnostic Technologies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Technologies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Technologies Product Solution and Service
Table 21. Date of Enter into Companion Diagnostic Technologies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Companion Diagnostic Technologies Revenue Market Share by Type (2016-2021)
Table 25. Global Companion Diagnostic Technologies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Companion Diagnostic Technologies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Companion Diagnostic Technologies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Companion Diagnostic Technologies Revenue Market Share by Application (2016-2021)
Table 29. Global Companion Diagnostic Technologies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Companion Diagnostic Technologies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Companion Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Companion Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Companion Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Companion Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Companion Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Companion Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Companion Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Companion Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Companion Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Companion Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Companion Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Companion Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Companion Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Companion Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Companion Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Companion Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Companion Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Companion Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Dako (Agilent Technologies) Company Details
Table 62. Dako (Agilent Technologies) Business Overview
Table 63. Dako (Agilent Technologies) Companion Diagnostic Technologies Product
Table 64. Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 65. Dako (Agilent Technologies) Recent Development
Table 66. Qiagen Company Details
Table 67. Qiagen Business Overview
Table 68. Qiagen Companion Diagnostic Technologies Product
Table 69. Qiagen Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 70. Qiagen Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Companion Diagnostic Technologies Product
Table 74. Roche Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Companion Diagnostic Technologies Product
Table 79. Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 80. Abbott Laboratories Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Companion Diagnostic Technologies Product
Table 84. Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. bioMerieux Company Details
Table 87. bioMerieux Business Overview
Table 88. bioMerieux Companion Diagnostic Technologies Product
Table 89. bioMerieux Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 90. bioMerieux Recent Development
Table 91. Myriad Genetics Company Details
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Companion Diagnostic Technologies Product
Table 94. Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 95. Myriad Genetics Recent Development
Table 96. Resonance Health Ltd. Company Details
Table 97. Resonance Health Ltd. Business Overview
Table 98. Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 99. Resonance Health Ltd. Recent Development
Table 100. Leica Microsystems Company Details
Table 101. Leica Microsystems Business Overview
Table 102. Leica Microsystems Companion Diagnostic Technologies Product
Table 103. Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 104. Leica Microsystems Recent Development
Table 105. Danaher Company Details
Table 106. Danaher Business Overview
Table 107. Danaher Companion Diagnostic Technologies Product
Table 108. Danaher Revenue in Companion Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 109. Danaher Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Technologies Market Share by Type: 2020 VS 2027
Figure 2. Immunohistochemistry Features
Figure 3. Molecular Diagnostics Features
Figure 4. Global Companion Diagnostic Technologies Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Auto immune & Inflammation Case Studies
Figure 9. Virology Case Studies
Figure 10. Others Case Studies
Figure 11. Companion Diagnostic Technologies Report Years Considered
Figure 12. Global Companion Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Companion Diagnostic Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Companion Diagnostic Technologies Market Share by Regions: 2020 VS 2027
Figure 15. Global Companion Diagnostic Technologies Market Share by Regions (2022-2027)
Figure 16. Global Companion Diagnostic Technologies Market Share by Players in 2020
Figure 17. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Technologies as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostic Technologies Revenue in 2020
Figure 19. Global Companion Diagnostic Technologies Revenue Market Share by Type (2016-2021)
Figure 20. Global Companion Diagnostic Technologies Revenue Market Share by Type (2022-2027)
Figure 21. North America Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Companion Diagnostic Technologies Market Share by Type (2016-2027)
Figure 23. North America Companion Diagnostic Technologies Market Share by Application (2016-2027)
Figure 24. North America Companion Diagnostic Technologies Market Share by Country (2016-2027)
Figure 25. United States Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Companion Diagnostic Technologies Market Share by Type (2016-2027)
Figure 29. Europe Companion Diagnostic Technologies Market Share by Application (2016-2027)
Figure 30. Europe Companion Diagnostic Technologies Market Share by Country (2016-2027)
Figure 31. Germany Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Companion Diagnostic Technologies Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Companion Diagnostic Technologies Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Companion Diagnostic Technologies Market Share by Region (2016-2027)
Figure 41. China Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Companion Diagnostic Technologies Market Share by Type (2016-2027)
Figure 49. Latin America Companion Diagnostic Technologies Market Share by Application (2016-2027)
Figure 50. Latin America Companion Diagnostic Technologies Market Share by Country (2016-2027)
Figure 51. Mexico Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Companion Diagnostic Technologies Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Companion Diagnostic Technologies Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Companion Diagnostic Technologies Market Share by Country (2016-2027)
Figure 57. Turkey Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Companion Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Dako (Agilent Technologies) Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 61. Qiagen Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 63. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 65. bioMerieux Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 66. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 67. Resonance Health Ltd. Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 68. Leica Microsystems Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 69. Danaher Revenue Growth Rate in Companion Diagnostic Technologies Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---